Jagsonpal Pharmaceuticals Ltd. - Research Center
507789 JAGSNPHARM Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Sales | 136.13 | 117.98 | 121.12 | 106.61 | 119.49 |
| Operating profit | 26.52 | 17.00 | 20.08 | 6.24 | 19.56 |
| Interest | 0.44 | 0.37 | 0.04 | 0.12 | 0.17 |
| Gross profit | 29.18 | 20.90 | 21.48 | 8.35 | 20.49 |
| EPS (Rs) | 2.54 | 2.28 | 2.04 | 0.83 | 2.16 |
Half yearly
results in details
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Other income | 3.10 | 4.27 | 1.43 | 2.23 | 1.11 |
| Stock adjustment | -2.99 | 2.38 | 4.66 | 2.51 | 3.10 |
| Raw material | 9.59 | 12.43 | 18.77 | 17.46 | 22.96 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 31.41 | 25.41 | 29.87 | 29.21 | 28.47 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 71.60 | 60.77 | 47.74 | 51.19 | 45.40 |
| Provisions made | - | - | - | - | - |
| Depreciation | 3.41 | 0.85 | 0.40 | 1.02 | 0.51 |
| Taxation | 5.69 | 5.10 | 4.29 | 1.91 | 5.83 |
| Net profit / loss | 16.79 | 14.95 | 13.33 | 5.43 | 14.16 |
| Extra ordinary item | -3.29 | - | -3.46 | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 13.24 | 13.10 | 13.10 | 13.10 | 13.10 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 19.48 | 14.41 | 16.58 | 5.85 | 16.37 |
| GPM (%) | 20.96 | 17.10 | 17.52 | 7.67 | 16.99 |
| NPM (%) | 12.06 | 12.23 | 10.88 | 4.99 | 11.74 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis